Angola vs Moldova: Antiretroviral therapy coverage for PMTCT
Angola
79.0%
in 2024
Moldova
79.0%
in 2024
Angola rank
43rd
Moldova rank
43rd
Antiretroviral therapy coverage for PMTCT over time
- Angola
- Moldova
How they compare
Angola currently reports 79.0% against 79.0% in Moldova, a difference of 0.0%.
Across all 25 years both countries report, Moldova has been ahead every year.
Angola ranks 43rd and Moldova ranks 43rd of 84 countries.
Moldova has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Angola | Moldova | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 17.9% | 13.4% | Moldova |
| 2010s | 25.0% | 62.8% | 37.8% | Moldova |
| 2020s | 69.0% | 81.4% | 12.4% | Moldova |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Angola or Moldova?
- Angola, at 79.0% against 79.0% in Moldova as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Angola and Moldova?
- 0.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Moldova?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and Moldova rank globally for antiretroviral therapy coverage for pmtct?
- Angola ranks 43rd and Moldova ranks 43rd of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).